Crystalline imidazo[4,5-b]pyridine compound, pharmaceutical compositions, and their use in treating medical conditions

Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof

CRYSTALLINE CARBAZOLE DERIVATIVE

METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF

Crystalline salt forms of Boc-D-Arg-DMT-Lys-(Boc)-Phe-NH

SALTS AND CRYSTAL FORMS OF GABA-A POSITIVE ALLOSTERIC MODULATOR

Process for preparing 7H-pyrrolo[2,3-d]pyrimidine derivatives and synthetic intermediates thereof

DIARYL MACROCYCLES AS MODULATORS OF PROTEIN KINASES

CRYSTALLINE L-ARGININE SALT OF (R)-2-(7-(4-CYCLOPENTYL-3-(TRIFLUOROMETHYL)BENZYLOXY)-1,2,3, 4-TETRAHYDROCYCLO-PENTA [B]INDOL-3-YL)ACETIC ACID(COMPOUND1) FOR USE IN SIPI RECEPTOR-ASSOCIATED DISORDERS

A PHARMACEUTICAL SALT OF AN ARYLPYRROLE DERIVATIVE

CO-CRYSTAL OF COENZYME QH AND NICOTINAMIDE, PREPARATION METHOD THEREFOR AND USE THEREOF

SALTS AND CRYSTALLINE FORMS OF A PD-1/PD-L1 INHIBITOR

NAPHTHYRIDINE COMPOUNDS AS JAK KINASE INHIBITORS

CRYSTAL FORMS OF AN ANTI-SARS COV-2 AGENT

Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of making

SALT FORM AND CRYSTAL FORM OF PYRAZOLE SUBSTITUTED IMIDAZO[1,2- A]QUINOXALINE DERIVATIVE

ION CHANNEL MODULATORS

CRYSTALLINE FORMS OF 5-(3,4-DIFLUOROBENZYL)-8-((1R,4R)-4-METHYLCYCLOHEXYL)-6,9-DIOXO-2,5,8-TRIAZASPIRO[3.5]NONANE-2-CARBALDEHYDE

COCRYSTAL

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

NOVEL CRYSTALLINE FORMS OF 1-(4-{[6-AMINO-5-(4-PHENOXY-PHENYL)-PYRIMIDIN-4-YLAMINO]-METHYL}-4-FLUORO-PIPERIDIN-1-YL)-PROPENONE, SALT FORMS THEREOF, AND PROCESSES TO OBTAIN

Polymorphs of (2S,5R)-5-(2-chlorophenyl)-1-(2′-methoxy-[1,1′-biphenyl]-4-carbonyl)pyrrolidine-2-carboxylic acid and preparation processes thereof

BRANCHED-CHAIN AMINO ACID CRYSTALLIZATION METHOD CAPABLE OF SUSTAINABLY CYCLING AMMONIA

BIS(FLUOROSULFONYL)IMIDE SALTS AND PREPARATION METHOD THEREOF

Enhanced perovskite materials for photovoltaic devices

PROCESSES FOR THE PREPARATION OF ZANUBRUTINIB AND INTERMEDIATES THEREOF

POLYMORPHS OF AVAPRITINIB AND METHODS FOR PREPARING THE POLYMORPHS

AZA-ERGOLINE DERIVATIVE AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

POLYMORPH OF LATREPIRDINE DIHYDROCHLORIDE

INJECTABLE LURASIDONE SUSPENSION AND PREPARATION METHOD THEREFOR

Solid state forms of Belumosudil and Belumosudil salts

PHARMACEUTICALLY ACCEPTABLE SALTS OF PSILOCIN AND USES THEREOF

SOLABEGRON ZWITTERION AND USES THEREOF

Method of synthesizing thyroid hormone analogs and polymorphs thereof

SHP2 PHOSPHATASE INHIBITORS AND METHODS OF MAKING AND USING THE SAME

SOLID FORMS OF {[5-(3-CHLOROPHENYL)-3-HYDROXYPYRIDINE-2-CARBONYL]AMINO}ACETIC ACID, COMPOSITIONS, AND USES THEREOF

PHTHALOCYANINE COMPOUND

Crystalline form of (s)-7-(1-acryloylpiperidin-4-yl)- 2-(4-phenoxyphenyl)-4,5,6,7-tetra- hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof

Polymorph of (1S,2S,3S,5R)-3-((6-(difluoromethyl)-5-fluoro-1,2,3,4-tetrahydroisoquinolin-8-yl)oxy)-5-(4-methyl-7H-pyrrolo[2,3-D]pyrimidin-7-yl)cyclopentane-1,2-diol

COCRYSTALLINE FORMS OF FGFR3 INHIBITORS

INDAZOLE INHIBITORS OF THE WNT SIGNAL PATHWAY AND THERAPEUTIC USES THEREOF

SALT OF NITROGEN-CONTAINING FUSED HETEROCYCLIC COMPOUND OR CRYSTAL FORM THEREOF, AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF

A CRYSTALLINE FORM OF (4-METHYL-2-[1,2,3]TRIAZOL-2-YL-PHENYL)-[(R)-3-(3-[1,2,3]TRIAZOL-2-YL-BENZYL)-MORPHOLIN-4-YL]-METHANONE

Polymorphisms of HM30181 mesylate

MARALIXIBAT SOLID FORMS, INTERMEDIATES AND PROCESSES OF MAKING SAME

Salts of Viloxazine

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

2-HYDROXY-5-[2-(4-(TRIFLUOROMETHYLPHENYL)ETHYLAMINO)]BENZOIC ACID CRYSTAL FORMS AND PREPARATION METHOD THEREFOR

COMPOSITIONS AND METHODS RELATED TO BICYCLO[2.2.1] HEPTANAMINE-CONTAINING COMPOUNDS

MEBENDAZOLE POLYMORPH FOR TREATMENT AND PREVENTION OF TUMORS

Crystalline solids of nicotinic acid mononucleotide and esters thereof and methods of making and use

COMPOSITIONS FOR TREATMENT OF OCULAR DISEASES

CRYSTALLINE SALTS OF A PLASMA KALLIKREIN INHIBITOR

INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF

SALTS OF A PI3Kdelta INHIBITOR, CRYSTALLINE FORMS, METHODS OF PREPARATION, AND USES THEREFORE

CRYSTAL FORM AND SALT FORM OF BROMINE DOMAIN PROTEIN INHIBITOR AND PREPARATION METHOD THEREFOR

HDAC INHIBITOR SOLID STATE FORMS

PYRIMETHAMINE CRYSTAL FORM

Pharmaceutically acceptable salts and compositions thereof

SALTS AND ESTERS OF APX3330 AND THERAPEUTIC USES THEREOF

HYDROXYALKANOIC ACID CRYSTAL PRODUCTION METHOD AND HYDROXYALKANOIC ACID CRYSTAL POLYMORPH

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

PHARMACEUTICAL PROCESS AND INTERMEDIATES

Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof

CRYSTALLINE FORM OF A PIPERAZINYL-THIAZOLE DERIVATIVE

CRYSTAL FORM OF LANIFIBRANOR, PREPARATION METHOD THEREFOR, AND USE THEREOF

CRYSTAL FORM OF ANTI-INFLUENZA VIRUS COMPOUND, PREPARATION METHOD FOR CRYSTAL FORM, AND USE OF CRYSTAL FORM

PHARMACEUTICAL FORMULATION OF ODEVIXIBAT

CRYSTALLINE 4-((L-VALYL)OXY)BUTANOIC ACID

Forms and Formulations Of A Tyrosine Kinase Non-Receptor 1 (TNK1) Inhibitor

COMPOSITIONS AND METHODS FOR SOLIDIFIED FERMENTED ANIMAL FEED

CYTOSINE-TYPE BRIDGED NUCLEOSIDE AMIDITE CRYSTALS AND METHOD FOR PRODUCING SAME

Crystalline Polymorphs of a Muscarinic Acetylcholine Receptor Agonist

Method for preparing heterocyclic derivative compound, composition containing same compound, and hydrate of same compound

CRYSTALLINE FORMS OF 3-(IMIDAZO[1,2-B]PYRIDAZIN-3-YLETHYNYL)-4-METHYL-N-{4-[(4-METHYLPIPERAZIN-1-YL)METHYL]-3-(TRIFLUOROMETHYL)PHENYL}BENZAMIDE AND ITS MONO HYDROCHLORIDE SALT

SALTS OF PYRIDINYLMETHYLENEPIPERIDINE DERIVATIVES AND USES THEREOF

Polymorphs of pyrimidine cyclohexyl glucocorticoid receptor modulators

PROCESSES AND SYSTEMS FOR CONVERTING CANNABINOIDS INTO CANNABINOID DERIVATIVES AND ISOLATING THE SAME

PROCESS FOR PREPARATION OF MAVACAMTEN AND SOLID STATE FORMS THEREOF

CROMOLYN METAL COMPLEXES AS ENHANCED PHARMACEUTICAL FORMULATIONS AND METHOD OF USING THE SAME

GREMLIN-1 CRYSTAL STRUCTURE AND INHIBITORY ANTIBODY

De novo design of potent and selective interleukin mimetics

SOLID FORMS OF A MODULATOR OF HEMOGLOBIN

OXAZOLE COMPOUND CRYSTAL

Polypeptide Integrin Antagonists

Phenylcarbamate crystalline form and method for manufacturing the same

METHOD FOR PREPARING HIGH-BULK-DENSITY IBUPROFEN SPHERICAL CRYSTAL AND PRODUCT THEREOF

Method for preparing heterocyclic derivative compound, composition containing same compound, and hydrate of same compound

SOLID STATE FORMS

POLYMORPHS OF THE HYDROCHLORIDE SALT OF LINAPRAZAN GLURATE

SSTR4 AGONIST SALTS

LAUROLACTAM PREPARATION METHOD, SYNTHESIZING DEVICE THEREFOR, LAUROLACTAM COMPOSITION PREPARED THEREBY, AND POLYLAUROLACTAM PREPARATION METHOD USING SAME

Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof

SOLID FORMS OF AN SGC STIMULATOR

GLP-1 Receptor Agonists and Uses Thereof

COCRYSTAL OF A CDK INHIBITOR

PROCESSES AND INTERMEDIATE FOR THE LARGE-SCALE PREPARATION OF 2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDINE-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE HEMISUCCINATE, AND PREPARATION OF 2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDINE-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE ACETATE

SOLID FORMS OF A COMPOUND

AMORPHOUS MELANOCORTIN RECEPTOR AGONIST AND METHOD FOR PREPARING SAME

METHOD FOR PREPARING DISODIUM 5'-GUANYLATE HEPTAHYDRATE CRYSTAL

SOLID FORMS OF A NUCLEOSIDE ANALOGUE AND USES THEREOF

CRYSTALLINE FORM OF HETEROCYCLIC COMPOUND AS PROTEIN KINASE INHIBITOR

CRYSTALLINE FORM II OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD THEREFOR

Solid form of compound

CAPSID INHIBITORS FOR THE PREVENTION OF HIV

SOLID FORMS OF AN N-TERMINAL DOMAIN ANDROGEN RECEPTOR INHIBITOR AND USES THEREOF

Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof

CRYSTALLINE FORM OF A PHENOLIC TRPV1 AGONIST PRODRUG

AN IMPROVED HIGHLY EFFICIENT PROCESS FOR THE PREPARATION OF NINTEDANIB AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

CRYSTALLINE FORM III OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD THEREFOR

Cage silicate and method for producing the same

SOLID FORMS OF A NUCLEOSIDE ANALOGUE AND USES THEREOF

CO-CRYSTAL FORMS OF A NOVOBIOCIN ANALOG AND PROLINE

Crystalline forms and methods of producing crystalline forms of a compound

CRYSTALLINE FORMS OF 5-CHLORO-N4-[-2-(DIMETHYLPHOSPHORYL) PHENYL]-N2-{2-METHOXY-4-[4[(4-METHYLPIPERAZIN-1-YL) PIPERIDIN-1-YL] PHENYL} PYRIMIDINE-2,4-DIAMINE

Crystalline Solid Meglumine Salt Inhibitor of BCL and Methods of Making and Using Same

Crystal form of compound, and preparation method therefor and use thereof

COCRYSTALS OF UPADACITINIB

CRYSTALLINE COMPOSITION OF TILDACERFONT AND METHODS OF USE AND PREPARATION THEREOF

SALT AND CRYSTAL FORM OF HA INHIBITOR COMPOUND

CRYSTALLINE FORMS OF 5-[(1,1-DIOXIDO-4-THIOMORPHOLINYL)METHYL]-2-PHENYL-N-(TETRAHYDRO-2H-PYRAN-4-YL)-1H-INDOL-7-AMINE

CRYSTAL FORM OF FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITOR AND PREPARATION METHOD THEREFOR

CRYSTALLINE FORM I OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND METHOD FOR PREPARING SAME

Method of preparing indolin-2-one compound and method of using indolin-2-one

Crystalline 5-methoxy-dipropyl tryptamine compounds

INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF

METHOD OF TREATING SCLC AND MANAGING NEUTROPENIA

METHOD OF TREATING SCLC AND MANAGING HEPATOTOXICITY

STABLE LURBINECTEDIN COMPOSITION

METHODS FOR CRYSTALLIZATION OF DRUGS

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

SOLID STATE FORMS OF SUBSTITUTED PYRAZOLOPYRIMIDINES AND USES THEREOF

Salts and solid forms of (R)-1-(5-methoxy-1H-indol-1-yl)-N,N-dimethylpropan-2-amine

NOVEL FORMS OF ANTIVIRAL NUCLEOSIDES

SALT FORM USED AS CDC7 INHIBITOR AND CRYSTAL FORM THEREOF

SOLID FORMS OF 4-(3,3-DIFLUORO-2,2-DIMETHYL-PROPANOYL)-3,5-DIHYDRO-2H-PYRIDO[3,4-F][1,4]OXAZEPINE-9-CARBONITRILE

Crystalline hydrate of a JAK inhibitor compound

TABLET COMPRISING MODOFLANER AS AN ACTIVE COMPONENT

METHOD FOR OBTAINING CRYSTALLINE DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE

Methods and compositions for treating retina-associated disease using CCR3-inhibitors

Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus

SALT OF COMPOUND FOR DEGRADING BTK, CRYSTAL FORM THEREOF, AND USE THEREOF IN MEDICINE

PROCESS FOR THE PREPARATION OF (9S)-N-[3-(6-METHYLPYRIMIDIN-4-YL)-3-AZABICYCLO[3.2.1]OCTAN-8-YL]-9-(2,3,4-TRIFLUOROPHENYL)-6,7,8,9-TETRAHYDRO-5H-[1,2,4]TRIAZOLO[1,5-A]AZEPIN-2-AMINE AND ITS SOLID FORM

Crystal and amorphous form of tolebrutinib, preparation method therefor, and use thereof

Polymorphic compounds and uses thereof

Psilocybin and O-acetylpsilocin, salts and solid state forms thereof

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

CRYSTALLINE FORMS OF A TYK2 INHIBITOR

Crystalline Forms of 4-amino-N-[4-(methoxymethyl)phenyl]-7-(1-methylcyclopropyl)-6-(3-morpholinoprop-1-yn-1-yl)-7H-pyrrolo[2,3-d]pyrimidine-5-carboxamide

Processes for the Preparation of Multicomponent Crystalline Forms of Active Pharmaceutical Ingredients Using Solvent Vapour

CRYSTALLINE FORMS OF AN S1P RECEPTOR MODULATOR

Urea Co-Crystal of Apixaban, and Preparation Method Therefor

CRYSTALLINE FORM IV OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD THEREFOR

SOLID STATE FORMS OF ERDAFITINIB SALTS AND PROCESSES FOR PREPARATION OF ERDAFITINIB

Salts of obicetrapib and processes for their manufacture and intermediates thereof

SOLID STATE FORM OF LEMBOREXANT

Crystalline solid forms of salts of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use

Crystalline forms of a cannabinoid receptor type 1 (CB1) modulator and methods of use and preparation thereof

SIPONIMOD SALTS AND COCRYSTALS

TITANIUM HETEROMETALLIC METAL-ORGANIC SOLIDS, METHOD FOR OBTAINING THEM AND THEIR USES

SALT OF PYRROLOPYRIMIDINE COMPOUND, CRYSTALLINE FORM THEREOF, AND APPLICATION THEREOF

SOLID FORMS OF 4-(5-(4-FLUOROPHENYL)-6-(TETRAHYDRO-2H-PYRAN-4-YL)-1,5-DIHYDROPYRROLO[2,3-F]INDAZOL-7-YL)BENZOIC ACID

CRYSTALLINE PPAR-DELTA AGONIST

Crystalline forms of compositions comprising psilocin and psilocybin

SALTS AND SOLID FORMS OF (R)-1-(5-METHOXY-1H-INDOL-1-YL)-N,N-DIMETHYLPROPAN-2-AMINE

METHOD FOR PREPARING INTERMEDIATE FOR SYNTHESIS OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST

LYOPHILIZED PHARMACEUTICAL COMPOSITION AND USES OF A CRYSTALLIZED FORM OF LURBINECTEDIN

Solid forms of Alpha-1062 gluconate

Folate salts

PROCESS TOWARD THE MANUFACTURE OF (6R,10S)-10-{4-[5-CHLORO-2-(4-CHLORO-1H-1,2,3-TRIAZOL-1-YL)PHENYL]-6-OXO-1(6H)-PYRIMIDINYL}- 1-(DIFLUOROMETHYL)-6-METHYL-1,4,7,8,9,10-HEXAHYDRO-11,15-(METHENO)PYRAZOLO[4,3-B][1,7]DIAZACYCLOTETRADECIN-5(6H)-ONE

METHODS OF PREPARING HETEROARYL-KETONE FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS

CRYSTAL FORM OF RESMETIROM, PREPARATION METHOD THEREFOR, AND USE THEREOF

Niraparib Compositions

R-MDMA CRYSTAL FORMS

Crystalline forms of eravacycline

CRYSTALLINE FORMS OF QUINAZOLINONE COMPOUND AND PROCESS FOR PREPARING THE SAME

HIGH-EFFICIENCY CYCLIC PREPARATION METHOD FOR COLUMNAR TAURINE

METHODS OF TREATING SYSTEMIC SCLEROSIS AND IDIOPATHIC PULMONARY FIBROSIS

CRYSTALLINE FORMS OF IRAK DEGRADERS

CRYSTAL FORM OF FREE BASE OF INHIBITOR CONTAINING BICYCLIC RING DERIVATIVE AND PREPARATION METHOD AND APPLICATION OF CRYSTAL FORM

Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders

CRYSTALLINE FORM OF HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof

4-pivaloyloxy-n-methyltryptammonium chloride

Crystalline prostacyclin (IP) receptor agonist and uses thereof

Formulations of RBP4 inhibitors and methods of use

MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

CRYSTALLINE 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID

CRYSTAL FORM OF L-GLUFOSINATE AND PREPARATION METHOD AND USE THEREOF

CRYSTALLIZED FORM OF LURBINECTEDIN AND METHOD OF MAKING THE SAME

A LYOPHILIZED PHARMACEUTICAL COMPOSITION

PROCESS FOR PURIFYING NOROXYMORPHONE

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

SOLID FORMS OF JAK INHIBITOR AND PROCESS OF PREPARING THE SAME

SUCCINATE AND CRYSTAL FORM THEREOF AS THERAPEUTICS

CRYSTALLINE FORM II OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD THEREFOR

CRYSTAL FORMS OF 5-FLUORO-1-(4-FLUORO-3-(4-(PYRIMIDIN-2-YL)PIPERAZINE-1-CARBONYL)BENZYL)QUINAZOLINE-2,4(1H,3H)-DIONE AND PREPARATION THEREOF

BIOLOGICAL ACTIVITIES OF 5-(2-(4-(4-FLUORO-2-METHYL-1H-INDOL-5-YLOXY)-6-METHOXYQUINOLIN-7-YLOXY)ETHYL)-5-AZASPIRO[2.4]-HEPTAN-7-OL CRYSTALLINE, PHOSPHORIC ACID SALT AND ITS ENANTIOMERS

POLYMORPHS OF SUBSTITUTED ISOQUINOLINE-BASED RHO KINASE INHIBITORS

DEUTERATED HPK1 KINASE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF

Methods of manufacturing 14,15-epoxyeicosatrienoic acid analogs and improved therapeutic delivery of same

Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof

Compositions and methods for oral delivery of crystalline PRX-3140 potassium salt

PROCESS FOR RACEMIZING AND ISOLATING ATROPISOMERS OF 7-CHLORO-6-FLUORO-1-(2-ISOPROPYL-4-METHYLPYRIDIN-3-YL)PYRIDO[2,3-D]PYRIMIDINE-2,4(1H,3H)-DIONE

Solid forms of a dual RAF/MEK inhibitor

Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan

Solid state forms of Belumosudil and Belumosudil salts

CRYSTALLINE FORM OF SELINEXOR

CRYSTALLINE AND AMORPHOUS FORMS OF A DELTA-OPIOID MODULATOR

SOLID STATE FORMS OF PRALSETINIB AND PROCESS FOR PREPARATION THEREOF

PROCESS FOR PREPARATION OF TAFAMIDIS AND SALTS THEREOF

SUCCINATE SALTS OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1H-BENZO[D]IMIDAZOL-2-AMINE, PREPARATION THEREOF AND USE OF THE SAME

Crystalline forms of a pharmaceutical compound

METHOD OF TREATING SCLC AND MANAGING THROMBOCYTOPENIA

Lurbinectedin Composition and Methods Making the Same

FUNCTIONAL CRYSTALLINE SWEETENER

Nonlinear optical crystal of guanidinium tetrafluoroborate, preparation method and use thereof

NOVEL COCRYSTALS OF DEXAMETHASONE

Crystalline forms of a CD73 inhibitor and uses thereof

Method of treatment of symptoms of menopause

SOLID STATE FORMS OF LUMATEPERONE DITOSYLATE SALT

CRYSTAL FORMS OF GLP-1R AGONISTS AND USES THEREOF

CRYSTAL FORM OF MULTI-SUBSTITUTED BENZENE RING COMPOUND MALEATE, AND PREPARATION METHOD THEREFOR AND USE THEREOF

CRYSTALLINE FORM OF LIFITEGRAST, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

ENANTIOMERICALLY PURIFIED GPER AGONIST FOR USE IN TREATING DISEASE STATES AND CONDITIONS

CRYSTALLINE FORM III OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD THEREFOR

METHOD FOR REFINING ACESULFAME POTASSIUM

Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof

CRYSTALLINE SOLID FORMS OF N-{4-[(6,7-DIMETHOXYQUINOLIN-4-YL)OXY]PHENYL}-N'-(4-FLUOROPHENYL) CYCLOPROPANE-1,1-DICARBOXAMIDE, PROCESSES FOR MAKING, AND METHODS OF USE

CRYSTALLINE (R)-5-CARBAMOYLPYRIDIN-3-YL-2-METHYL-4-(3-(TRIFLUOROMETHOXY)BENZYL)PIPERAZINE-1-CARBOXYLATE, COMPOSITIONS AND METHODS OF USE THEREOF

Crystalline bis-miprocin fumarate

PHARMACEUTICAL COMPOSITION COMPRISING 5-METHOXY-N,N-DIMETHYLTRYPTAMINE

FREE BASE CRYSTALLINE FORM OF A COMPLEMENT COMPONENT C5a RECEPTOR

SOLID STATE FORMS OF TRILACICLIB AND OF TRILACICLIB SALTS

PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF

Pharmaceutical formulations for the treatment of gastrointestinal disorders

CRYSTALLINE FORM I OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD THEREFOR

A STABLE CRYSTALLINE HYDRATE OF CLAZOSENTAN DISODIUM SALT

POLYMORPHIC FORMS OF RAD1901-2HCL

CRYSTALLINE SODIUM CHOLESTERYL SULFATE

CRYSTALLINE THIOCHOLESTEROL

ADVANTAGEOUS MORPHIC FORM OF AT-527 HEMI-SULFATE SALT

CRYSTAL FORMS OF PYRIDOPYRAZOLE COMPOUNDS AND PREPARATION METHOD THEREFOR

COCRYSTALS OF AN ADENOSINE A2B RECEPTOR ANTAGONIST

TETRAHYDROISOQUINOLINE DERIVATIVE AND USE THEREOF

CRYSTALLINE POLYMORPH FORM A OF A JAK INHIBITORAND METHODS FOR ITS PREPARATION

CRYSTAL FORM OF COMPOUND AND FUMARIC ACID, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING CORONAVIRUS-INDUCED DISEASES

SALT OF BENZOTHIAZOLE COMPOUND, AND CRYSTAL FORM AND USE THEREOF

TRIAZINE COMPOUND SALT, CRYSTAL FORM THEREOF, AND PRODUCTION METHOD THEREFOR

PROCESSES FOR THE PREPARATION OF IVABRADINE HCl POLYMORPHS

CRYSTAL FORM OF PYRIDINYLPHENYL COMPOUND AND PREPARATION METHOD THEREFOR

Methods for making and using endoxifen

DICLOFENAC PRODRUG AND USE OF THE SAME

PHARMACEUTICAL COMPOSITION CONTAINING PALBOCICLIB AND LETROZOLE

SOLID FORMS OF A TOLL-LIKE RECEPTOR MODULATOR

POLYMORPHIC FORMS OF (R)-2-HYDROXY-2-METHYL-4-(2,4,5-TRIMETHYL-3,6-DIOXOCYCLOHEXA-1,4-DIENYL)BUTANAMIDE

Solid form of (−)-Ambrox formed by a bioconversion of homofarnesol in the presence of a biocatalyst

Method of manufacturing a pharmaceutical composition

Solution phase synthesis of β-turn peptidomimetic cyclic salts

CRYSTALLINE SODIUM CHOLESTERYL SULFONATE

Crystal of Thyroid Hormone B Receptor Agonist, Process for Preparing The Same and Use Thereof

SPIRO-SULFONAMIDE DERIVATIVES AS INHIBITORS OF MYELOID CELL LEUKEMIA-1 (MCL-1) PROTEIN

Salts and polymorphs of certain MCL-1 inhibitors

LSD DERIVATIVES, SYNTHESIS & METHOD FOR TREATMENT OF DISEASES AND DISORDERS

Crystalline forms of a KRas G12C inhibitor

SOLID FORMS OF A CDK4 INHIBITOR

MODULATOR OF THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS, METHODS OF TREATMENT, AND PROCESS FOR MAKING THE MODULATOR

CRYSTALLINE FORMS OF A MAGL INHIBITOR

SOLID FORMS OF (S)-1-((2',6-BIS(DIFLUOROMETHYL)-[2,4'-BIPYRIDIN]-5-YL)OXY)-2,4-DIMETHYLPENTAN-2-AMINE AND SALTS THEREOF

POLYMORPHS OF BIS(FLUOROALKYL)-1,4-BENZODIAZEPINONE COMPOUNDS AND USES THEREOF

SOLID STATE FORMS OF GEFAPIXANT AND PROCESS FOR PREPARATION THEREOF

Synthesis of Sulfonamide Intermediates

CRYSTALLINE FORMS OF OMADACYCLINE, METHODS OF SYNTHESIS THEREOF AND METHODS OF USE THEREOF

PROCESS FOR ISOLATING 2-(4'-DIETHYLAMINO-2'-HYDROXYBENZOYL)BENZOIC ACID HEXYL ESTER

CO-CRYSTAL OF KETOPROFEN, LYSINE AND GABAPENTIN, PHARMACEUTICAL COMPOSITIONS AND THEIR MEDICAL USE

TAPINAROF POLYMORPHS

PHARMACEUTICALLY ACCEPTABLE SALT OF CARIPRAZINE AND CRYSTAL FORM THEREOF, AND PREPARATION METHOD THEREFOR AND USE THEREOF

METHOD FOR PRODUCING BICYCLIC PHOSPHORAMIDITE

Crystalline forms of (s)-2-ethylbutyl 2-(((s)-(((2r,3s,4r,5r)-5-(4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy) (phenoxy) phosphoryl)amino)propanoate

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

Type II crystalline topramezone sodium salt hydrate, preparation method therefor and use thereof

CRYSTAL FORM OF POLYCYCLIC ANAPLASTIC LYMPHOMA KINASE INHIBITOR

Polymorphs of [2-(1H-indol-3-yl)-1H-imidazol-4- yl] (3,4,5-trimethoxyphenyl)methanone and its salts

HETEROCYCLIC COMPOUNDS AND METHODS OF USE

Highly purified batches of pharmaceutical grade migalastat and methods of producing the same

POLYMORPHS OF 5-BROMO-6-CHLORO-3-INDOXYL CAPRYLATE

CRYSTALLINE 5-METHOXY-N,N-DIALLYLTRYPTAMINE COMPOUNDS

Crystalline psilacetin derivatives

COMPOSITION COMPRISING A BENZOATE SALT OF 5-METHOXY-N,N-DIMETHYLTRYPTAMINE

PURE FORMS OF CRYSTALLINE ATICAPRANT

PROCESS FOR SYNTHESIZING TRIARYLMETHANE SULFONE COMPOUNDS

COMPOUNDS AND THEIR USE

METHODS FOR SYNTHESIZING ANHYDROUS LACTIC ACID

PREPARATION AND USES OF OBETICHOLIC ACID

CRYSTALLINE FORM OF SHP2 INHIBITOR, AND COMPOSITION THEREOF, PREPARATION METHOD THEREFOR, AND USE THEREOF

SOLID FORMS OF AN S1P-RECEPTOR MODULATOR

SOLID STATE FORMS OF SEP-363856 AND PROCESS FOR PREPARATION THEREOF

DOSAGE FORM COMPOSITIONS COMPRISING AN INHIBITOR OF BRUTON'S TYROSINE KINASE

Methods for the treatment of gastro-intestinal disorders

Processes and intermediates for the preparation of soluble guanylate cyclase stimulators